ライフサイエンスコーパス: enrollee

1 ctible health plans, 12.1 operations/100,000 enrollees).

2 eby the program's environmental benefits per enrollee.

3 were collected and tested from 2885 (78%) of enrollees.

4 viral therapy (ART) reinitiation in Medicaid enrollees.

5 All communities contributed >/=20 enrollees.

6 dermatologists is often limited for Medicaid enrollees.

7 %-64%) at 1 year post discharge among Part D enrollees.

8 ation-level health indicators among Medicare enrollees.

9 Informed consent was obtained from potential enrollees.

10 mary care for the growing number of Medicaid enrollees.

11 oss Blue Shield of Texas [BCBSTX]) for Texas enrollees.

12 SUD treatment facilities that serve Medicaid enrollees.

13 nly if an infrastructure exists to serve new enrollees.

14 exists across local communities to serve new enrollees.

15 are fee-for-service and commercially insured enrollees.

16 -based treatment infrastructure for Medicaid enrollees.

17 of death among antiretroviral therapy (ART) enrollees.

18 Infection was confirmed in 60 of 66 (91%) enrollees.

19 e scope of medical services required for new enrollees.

20 fitness benefits than among the 4097 earlier enrollees.

21 on rates are primarily derived from Medicare enrollees.

22 ith healthier enrollees to plans with sicker enrollees.

23 % CI, 4.4 to 11.7), as compared with earlier enrollees.

24 was the least common, being reported in 167 enrollees.

25 have predominantly been reported in Medicare enrollees.

26 y insured individuals and Medicare Advantage enrollees.

27 gth of stay and these outcomes among hospice enrollees.

28 ries-related treatment visits among Medicaid enrollees.

29 l therapy was identified from all Medicare D enrollees.

30 %); MRI use increased from 17 to 65 per 1000 enrollees, 10% annual growth (95% CI, 3.3%-16.5%); and u

31 Among dual enrollees, 10% exclusively used the VA for outpatient an

32 Seventy-six percent of enrollees (1111/1470) requested to participate in future

33 Among 7083 enrollees, 1342 (19%) tested positive for influenza A(H3

34 Among 1 million randomly sampled enrollees, 14 523 adult CHB patients were identified fro

35 Among 9710 enrollees, 1868 (19%) tested positive for influenza A(H3

36 Among 8,845 enrollees, 2,722 (31%) tested positive for influenza, in

37 ribing daily hospital admissions of Medicare enrollees (23.7 million fee-for-service beneficiaries [a

38 Of 152,163 eligible enrollees, 2925 (1.9%) developed POAG.

39 edicine use decreased from 32 to 21 per 1000 enrollees, 3% annual decline (95% CI, 7.7% decline to 1.

40 und rates increased from 134 to 230 per 1000 enrollees, 3.9% annual growth (95% CI, 3.0%-4.9%).

41 Among the 11 161 907 eligible enrollees, 40 892 (0.4%) underwent vitrectomy over the 1

42 During the study period, 81/1,490 enrollees (5.4%) died by suicide.

43 creased after 2004 from 0.24 to 3.6 per 1000 enrollees, 57% annual growth.

44 Among having randomly sampled 1 million enrollees, 6,251 adult CHC patients were identified from

45 te (69.4%), randomized (64.8%), and had <100 enrollees (66.3%).

46 During the study period, 655,613 enrollees (68.8%) underwent at least one imaging procedu

47 Of 6991 enrollees, 6979 (mean age, 65.9 years; eGFR, 54.6 mL/min

48 ical data were obtained prospectively in 146 enrollees (73+/-10 years) undergoing dual chamber pacema

49 dominant modality of diagnosis in all RIETE enrollees (78.2% [99% CI, 77.6-78.7]); including pregnan

50 Of 12,610 enrollees (81% of eligible household members), 29% were

51 uating rates of bariatric procedures/100,000 enrollees, 90-day mortality, readmission rate and paymen

52 dditional annual hospital admissions per 100 enrollees (95% CI, 1.8 to 2.6), 13.4 more annual inpatie

53 .6), 13.4 more annual inpatient days per 100 enrollees (95% CI, 10.2 to 16.6), and an increase of 0.7

54 19.8 fewer annual outpatient visits per 100 enrollees (95% confidence interval [CI], 16.6 to 23.1),

55 Of 1 381 477 eligible enrollees, 977 (0.1%) developed NAION during a mean +/-

56 Among the 952,352 included first-time enrollees, a 1-star higher rating was associated with a

57 A small subset of enrollees account for a large proportion of all glaucoma

58 are Advantage enrollees, this study assesses enrollee adoption by type of benefit (eg, caregiver supp

59 sured patients aged 45-64 years and Medicare enrollees after 2012, although at half the prior rate (i

60 ospective cohort study of Tennessee Medicaid enrollees age >=18 years initiating long-acting opioids

61 to rates among noninstitutionalized Medicare enrollees age 65 and older undergoing the same procedure

62 All enrollees aged >/=21 years in a US managed-care network

63 ort design, a national sample of new veteran enrollees aged 18-35 years was studied.

64 All enrollees aged 21 years or older in a United States mana

65 assessed in 87,736 fee-for-service Medicare enrollees aged 65 years or older diagnosed with advanced

66 pulation of approximately 6 million Medicare enrollees aged 65 years or older.

67 mortality among Cardiovascular Health Study enrollees aged 65-98 years who, at baseline assessment i

68 Enrollees also had higher unadjusted risks of 30-day all

69 individuals are similar to those in Medicare enrollees, although at lower rates.

70 Differing distributions of enrollees among health plans accounted for 39 to 59% of

71 proved appointment availability for Medicaid enrollees among participating providers without generati

72 Enrollee and procedure counts were multiplied by 5 to es

73 2.3 million to reimburse care provided to MA enrollees and collected $9.4 million (18% of the billed

74 iven low rates of hospice use among Medicaid enrollees and considerable evidence of suffering at the

75 by both increases in the number of Medicare enrollees and in per capita utilization.

76 s supplemented with Medicare claims for dual-enrollees and meteorological data from 1999-2010.

77 eadmission for AMI or stroke) between Part D enrollees and nonenrollees, after adjustment for patient

78 ctors, CRN was similar among Medicare Part D enrollees and nonenrollees.

79 ve access to dermatology care among Medicaid enrollees and played an especially important role for th

80 plans, the differences between the 1154 new enrollees and the 3910 earlier enrollees were 1.5 percen

81 sing numbers and diversity of medical school enrollees and the US physician workforce size and compos

82 rcial claims, rates were calculated per 1000 enrollees, and trends were reported over time in aggrega

83 ternatively, enrollment costs can dampen per-enrollee benefits if their correlation with status-quo c

84 m 1380 to 1945 biopsies per 100,000 Medicare enrollees between 1997 and 2008, which represents a comp

85 ncreased from 693.9 to 947.2 visits per 1000 enrollees between 1999 and 2007 (rate difference, 253.3;

86 fertilization (IVF) rates among health plan enrollees between 2012 and 2017 after a large US empoloy

87 Among Medicare managed care enrollees carrying a diagnosis of RA between 2005 and 20

88 nd the representativeness of the SHIFT trial enrollees compared with those in the Swedish Heart Failu

89 with suppressed HIV: 5 of 6 treatment-naive enrollees completed A5335S.

90 ebo capsules enriched with 81 mg aspirin; 46 enrollees completed the trial.

91 and 2002, respectively) for two groups: FEHB enrollees diagnosed in 1999 with bipolar disorder, major

92 Cases were Medicare enrollees diagnosed with CRC between 1996 and 2013; up t

93 d from 2001 to 2013 (664 to 1058 per 100,000 enrollees), driven by HCV and nonalcoholic fatty liver d

94 Of the 11 160 833 enrollees eligible for this study, 376 680 (3.4%) had 1

95 nd continued to provide SOC practices to all enrollees: enhanced contact with interventionist (EC) (b

96 Expenditures per enrollee for mental health and substance abuse services

97 her than among noninstitutionalized Medicare enrollees for all procedures (surgery for bleeding duode

98 urred higher expenditures for commercial HMO enrollees for professional, hospital, laboratory, pharma

99 e) in a population of 12 million US Medicare enrollees for the period 2000-2008.

100 d >/=65 years] per year; 85% of all Medicare enrollees) for the period 1999 to 2010 in 1943 counties

101 ed seventy-seven eligible PCPs of consenting enrollees from 8 regional or urban Ontario CR programs w

102 mmercially insured and Medicare managed care enrollees from a large, national US managed care health

103 udy (GHS) cohort that included 4335 eligible enrollees from among 5000 subjects who participated in t

104 We studied enrollees from the Assessment, Serial Evaluation, and Su

105 Of 83 potential enrollees from the DATA study, 77 completed at least one

106 For commercial health insurance enrollees from the US, administrative claims data were d

107 for dementia, AD, and PD among all Medicare enrollees >/= 65 years in 50 northeastern U.S. cities (1

108 cular and respiratory disease among Medicare enrollees >/= 65 years of age during the 12-year period

109 s for cardiovascular diseases among Medicare enrollees >/= 65 years of age.

110 ared with white participants, Asian-American enrollees had a 177% increased risk of developing MH (ad

111 aged-care plan for at least 4 years in which enrollees had at least 2 visits to an eye care provider

112 th acute conjunctivitis by ophthalmologists, enrollees had considerably higher odds of antibiotic pre

113 Enrollees had HCV and were listed for liver transplantat

114 More affluent and educated enrollees had higher odds of filling antibiotic prescrip

115 Enrollees had HIV-1 RNA <40 copies/ml on ART.

116 pulations in other states, Massachusetts AQC enrollees had lower spending growth and generally greate

117 Results In almost all instances, Medicare enrollees had the highest utilization rate for each moda

118 ms for a contemporary population of Medicare enrollees has not been studied.

119 Among Medicaid enrollees, HCV/HIV coinfection was associated with incre

120 to a sustained period of slow growth in per-enrollee health care spending and improvements in health

121 costs can increase a program's benefits per enrollee if they are systematically higher for (and thus

122 Factors associated with being an enrollee in the costliest 5% for glaucoma-related charge

123 .4% (from 3.2 procedures per 10,000 Medicare enrollees in 1991 to 5.1 procedures per 10,000 in 2010).

124 2% (from 31.2 procedures per 10,000 Medicare enrollees in 1991 to 62.1 procedures per 10,000 in 2010)

125 ; CT examinations increased from 52 per 1000 enrollees in 1996 to 149 per 1000 in 2010, 7.8% annual i

126 Black enrollees in 2006 and 2011 were substantially less likel

127 ferral region rates of PCI per 1000 Medicare enrollees in 2007 on the regions' rates of providing >/=

128 All charts from HMO-health plan enrollees in 2007 were reviewed (n = 1,116).

129 neurologic and allergic adverse events among enrollees in 8 medical care organizations (the Vaccine S

130 For every additional optometrist per 100 000 enrollees in a community, the hazard of surgery increase

131 A total of 340 372 enrollees in a large nationwide United States managed ca

132 s nested case-control study was among female enrollees in a large U.S. integrated health care deliver

133 Records of almost 8 million enrollees in a national managed-care network throughout

134 Average spending increased for enrollees in both the intervention and control groups in

135 n 2009 with spending among privately insured enrollees in control states.

136 sed all-cause admission rates among Medicare enrollees in each HRR.

137 Claims data from a 20% sample of enrollees in fee-for-service Medicare throughout the Uni

138 All electronic medical records for enrollees in Kaiser Permanente Hawaii (n = 217,061) from

139 increased copayments for ambulatory care and enrollees in matched control plans--similar plans that m

140 Among elderly enrollees in Medicare Advantage health plans in 2011 who

141 t the increased use of prescription drugs by enrollees in Medicare Part D has had on spending for oth

142 use of outpatient and inpatient care between enrollees in Medicare plans that increased copayments fo

143 ge annual medical spending on claims for the enrollees in organizations that entered the AQC in 2009

144 interval [CI], 2.6 to 9.7) among the 755 new enrollees in plans that added fitness benefits than amon

145 usted absolute differences in proportions of enrollees in the 2 years, 7.9 percentage points and 10.3

146 Enrollees in the American College of Radiology Imaging N

147 Participants were enrollees in the Group Health Cooperative (Seattle, Wash

148 Participants were enrollees in the Group Health Cooperative aged 20-79 yea

149 ps in 2009, but the increase was smaller for enrollees in the intervention group--$15.51 (1.9%) less

150 From among 4,107 enrollees in the National Institute of Mental Health's S

151 Subjects were enrollees in the Vitamin D Antenatal Asthma Reduction Tr

152 an increase in the vitrectomy rates per 1000 enrollees in this large managed care network over the co

153 Nearly 60% of enrollees in this managed care network filled antibiotic

154 ely measured at baseline in a subset of 5488 enrollees in WHI cohorts.

155 AIT-treated enrollees incurred 38% ($6,637 vs $10,644, P<.0001) lowe

156 We then estimated the percentage of enrollees initiating opioid therapy who received a long-

157 a variety of strategies affecting potential enrollees, insurers, and healthcare providers are offere

158 federal financial assistance for Marketplace enrollees, introducing a public plan option in areas lac

159 during screening mammography among Medicare enrollees is associated with increased DCIS incidence, t

160 nts for ambulatory care were magnified among enrollees living in areas of lower income and education

161 ing a high volume of surgical care for their enrollees may benefit by critically evaluating the syste

162 various racial and ethnic groups of Medicare enrollees may contribute to persistent disparities in he

163 7.6 years) with newly diagnosed XFG and 7339 enrollees (median age 77.3 years) with newly diagnosed P

164 Among 192 eligible enrollees (median age 77.6 years) with newly diagnosed X

165 Among 2745 enrollees (median age 80.5 years) with preexisting XFG a

166 nsurers to provide medical care services for enrollees (Medicaid managed care plans).

167 tigated the impact of Mutuelles' coverage on enrollees' medical care utilization using logistic regre

168 We identified all enrollees newly diagnosed with acute conjunctivitis, cal

169 e therapy (IPT) was prescribed to <1% of ART enrollees not taking TB treatment.

170 Among enrollees of 2 US health plans, we compared Papanicolaou

171 is conducted among 18- to 49-year-old female enrollees of a large health care system in western Washi

172 82) and non-Hispanic white (NHW; n = 82,696) enrollees of Kaiser Permanente Northern California (KPNC

173 Enrollees of organizations that entered the AQC in 2010,

174 spital admissions among 9.2 million Medicare enrollees of the Northeast/Mid-Atlantic United States be

175 Trained field staff posed as either Medicaid enrollees or privately insured enrollees seeking new-pat

176 but not top quintile of facility to Medicaid enrollee per capita ratio), or high access (ie, top quin

177 ss (ie, top quintile of facility to Medicaid enrollee per capita ratio).

178 ding on claims grew an average of $62.21 per enrollee per quarter less than it did in the control coh

179 e 2000s through early 2010s (images per 1000 enrollees per year for Medicare: -301 [95% CI: -510, -92

180 ough at half the prior rate (images per 1000 enrollees per year for Medicare: 17 [95% CI: 6, 28]; com

181 rough the mid to late 2000s (images per 1000 enrollees per year for Medicare: 91 [95% confidence inte

182 ases (95% CI 0.63-0.83) per 100,000 Medicaid enrollees per year.

183 has reached 28% (n = 17,065) of the targeted enrollee population and more than 2 million biological s

184 regression assessed factors associated with enrollees' prescription of >/=1 glaucoma medication clas

185 All enrollees presented to outpatients clinics with acute re

186 The next 190 sequential enrollees received instruction from CEIs.

187 onic Renal Insufficiency Cohort (CRIC) study enrollees recruited from Kaiser Permanente Northern Cali

188 r of gastroenterology procedures per million enrollees remained largely unchanged in Medicare patient

189 The proportion of new enrollees reporting activity limitation was 10.4 percent

190 The proportion of enrollees reporting excellent or very good health was 6.

191 Main Outcomes and Measures: Proportion of enrollees requiring additional LTPs, hazard ratio with 9

192 ion classes prescribed and the proportion of enrollees requiring cataract or glaucoma surgery within

193 Among 2351 enrollees, rhinovirus was detected in 247 (11%).

194 In each enrollee's credentialing file, if there was a claim agai

195 Monitoring proportions of enrollees screened for TB, and incidence and determinant

196 ther Medicaid enrollees or privately insured enrollees seeking new-patient primary care appointments.

197 ng and quality of care for another insurer's enrollees served by the ACO.

198 We found no evidence that enrollees shifted their deforestation to nearby land.

199 these findings in a nonrandomized subset of enrollees show an HLA-specific vaccine effect on the tim

200 Among the 322,699 enrollees switching plans, a 1-star higher rating was as

201 factors and type of provider diagnosing the enrollee than by medical indication.

202 t entered the AQC in 2009 was $461 lower per enrollee than spending in the control states (P<0.001),

203 sharing, such as PPOs (20 operations/100,000 enrollees) than in HDHPs (high-deductible health plans,

204 ket plans for expenditures of any individual enrollee that exceed a high predetermined level.

205 Among elderly Medicare enrollees, the risk for interval CRC was higher in black

206 aling file, if there was a claim against the enrollee there was a narrative regarding each malpractic

207 available to HMO and PPO Medicare Advantage enrollees, this study assesses enrollee adoption by type

208 Among Mutuelles enrollees, those in the poorest expenditure quintile had

209 btained from January 26, 2012 (date of first enrollee), through May 1, 2015, to establish participant

210 spending increased from a mean of $2802 per enrollee to $3610 during this period (29% increase).

211 decrease in inpatient spending from $641 per enrollee to $373 and was driven primarily by an increase

212 11 were substantially less likely than white enrollees to have adequate control of blood pressure (ad

213 ve funds from insurance plans with healthier enrollees to plans with sicker enrollees.

214 The estimated VA health care costs for MA enrollees totaled $13.0 billion over 6 years, increasing

215 nt disorder (N=19,094) and privately insured enrollees unaffected by the policy in a comparison natio

216 The proportion of enrollees undergoing >/=1 VF test, FP, OOI, and no testi

217 Medicare enrollees undergoing an elective colectomy at a large te

218 and blacks were underrepresented relative to enrollees undergoing eye care for reasons other than cor

219 During the 15-year study period, enrollees underwent a total of 30.9 million imaging exam

220 A total of 821 Medicare enrollees underwent an elective colectomy and met inclus

221 d previously demonstrated savings among BCBS enrollees varied similarly across settings, services, an

222 All-cause 30-day death was more common among enrollees versus nonenrollees (4.0% versus 3.3%), but th

223 We identified all enrollees visiting an ED for ocular conditions identifie

224 pes, the average wait time for Medicaid-CHIP enrollees was 22 days longer than that for privately ins

225 The median age of enrollees was 27 years (range, 18-50); 52% were White (n

226 The mean age of enrollees was 30.4 +/- 15.7 months.

227 ess to provide appointments for new Medicaid enrollees was related to the size of increases in Medica

228 duced spending and improved quality for BCBS enrollees, was also associated with changes in spending

229 For each enrollee, we quantified medication adherence using the m

230 the 1154 new enrollees and the 3910 earlier enrollees were 1.5 percentage points or less for each me

231 At baseline, enrollees were 45% women, 82% white, mean (SD) age was 6

232 Nasopharyngeal swabs from enrollees were analyzed for the presence of RSV and othe

233 omplete parasitological data of 1860 (86.6%) enrollees were analyzed.

234 s, participants enrolled at sites with fewer enrollees were at higher risk for adverse outcomes (HR:

235 Rates of vitrectomy per 1000 enrollees were computed each year from 2001 through 2012

236 Enrollees were divided into three groups according to th

237 Enrollees were followed from their first prescription un

238 m 16 clinical research sites in 8 countries, enrollees were interviewed to assess willingness to take

239 Hispanic enrollees were less likely than whites in 2011 to have a

240 Enrollees were monitored continuously for >/=2 years bet

241 Eligible enrollees were pregnant women ages 18-45.

242 Enrollees were randomized to 2 cohorts: cohort A physici

243 Enrollees were randomly assigned as family units to eith

244 ontrol doses received the best dose, and new enrollees were randomly assigned to receive 200 IU/d or

245 The costliest 5% of enrollees were responsible for $10 202 871 (24%) of all

246 how representative RELAX-AHF clinical trial enrollees were to those patients with AHF found in inter

247 tted to hospitals in Tyrol; 675 (14%) of the enrollees were treated with alteplase.

248 There was no difference in the proportion of enrollees who developed adverse events after keratoplast

249 Of PHS enrollees who had blood collected at PHS II baseline (ap

250 reas of lower income and education and among enrollees who had hypertension, diabetes, or a history o

251 Our study sample included 63,817,512 enrollees who had not used opioids (mean, 15,897,673 per

252 idence of initial opioid prescriptions among enrollees who had not used opioids declined by 54%, from

253 rate of 115,378 prescriptions per 15,897,673 enrollees who had not used opioids.

254 Among 187 enrollees who had received a single implicated drug, ini

255 Of the 659357 enrollees who met inclusion criteria (391674 females and

256 Of the 492,488 enrollees who met inclusion criteria, 2283 (0.5%) develo

257 Of the 38 648 enrollees who met the inclusion criteria, 2187 underwent

258 Of the 494 165 enrollees who met the study inclusion criteria, 1302 (0.

259 data (20% sample) of 15 996 Medicare Part D enrollees who received a DES in 2006 to 2007.

260 incidence was estimated as the percentage of enrollees who received an initial opioid prescription am

261 e (1.2 mSv vs 2.3 mSv) and the proportion of enrollees who received high (>20-50 mSv) exposure (1.2%

262 d care network were analyzed to identify all enrollees who underwent 1 vitrectomy or more each year f

263 By 2010, 6.8% of enrollees who underwent imaging received high annual rad

264 Nearly one-quarter of enrollees who visited the ED for an ocular problem recei

265 Among the 3,625 enrollees who were HIV-negative at enrollment and comple

266 f 0.7 percentage points in the proportion of enrollees who were hospitalized (95% CI, 0.51 to 0.95),

267 ystem (intervention group) and for 1,351,446 enrollees whose PCPs were not in the system (control gro

268 We compared spending and quality among enrollees whose physician organizations entered the AQC

269 006 through 2016, we compared spending among enrollees whose physician organizations entered the AQC

270 We analyzed 2006-2009 claims for 380,142 enrollees whose primary care physicians (PCPs) were in t

271 ording to the ZIP Code of residence for each enrollee with the use of previously validated prediction

272 d included Medicare and commercial insurance enrollees with a new, adjudicated prescription for any o

273 Among 340 372 enrollees with acute conjunctivitis, 198 462 (58%) fille

274 Total spending was unchanged among enrollees with bipolar disorder and major depression but

275 cohorts that had a disproportionate share of enrollees with chronic mental health and medical conditi

276 Of 9311 enrollees with complete data, 7078 (76%) were influenza

277 nic health record data, was used to identify enrollees with continuous enrollment in the database for

278 ring a 10-year period, spending for Medicaid enrollees with depression increased substantially, with

279 The percentage of enrollees with depression who were hospitalized decrease

280 Disease severity was important; enrollees with end-organ damage caused by HTN had a 107%

281 Enrollees with established eye care professionals had a

282 e containing more than 1000 eyes of Medicare enrollees with glaucoma who underwent LTP in Oklahoma fr

283 Enrollees with hypertension (HTN) alone (aHR, 1.78; CI,

284 to an HIV behavioral risk study and compared enrollees with men who declined to enroll.

285 For some plans with a high share of enrollees with mental health conditions, underpayment wa

286 plans that have a disproportionate share of enrollees with mental health conditions.

287 Of the 56675 enrollees with newly diagnosed OAG, the mean proportion

288 dence interval [CI], $33 to $50) (74%) among enrollees with no previous drug coverage, $27 higher (95

289 ICD-9CM) billing codes were used to identify enrollees with nonexudative and exudative AMD.

290 Average glaucoma-related charges for enrollees with OAG were characterized in 6-month blocks

291 at the initial LTP was 77.7 (7.5) years for enrollees with ophthalmologist-performed LTP and 77.6 (8

292 Percentage of health plan enrollees with prediabetes who were prescribed metformin

293 community-dwelling, nonelderly disabled dual enrollees with schizophrenia (n = 5554) or bipolar disor

294 of elderly beneficiaries: Medicare Advantage enrollees with stable, uncapped, employer-based drug cov

295 esting; and from a reduction in spending for enrollees with the highest expected spending.

296 resulted in increased radiation exposure for enrollees, with a doubling in the mean per capita effect

297 demographics and comorbidities to a Medicare enrollee without cancer, and each pair was followed thro

298 A group of 87,307 Medicare enrollees without cancer were individually matched by ag

299 medical comorbidities to a group of Medicare enrollees without cancer, and each pair was followed thr

300 ased hazard of developing BRVO compared with enrollees without HTN (aHR, 2.07; CI, 1.75-2.45; P < 0.0